Author Question: The price used to sell goods or services between subsidiaries in a company is A) the tax ... (Read 67 times)

Lobcity

  • Hero Member
  • *****
  • Posts: 524
The price used to sell goods or services between subsidiaries in a company is
 
  A) the tax avoidance price.
  B) set at the marginal cost of the producing subsidiary.
  C) determined by the minimum of the average cost curve.
  D) a transfer price.

Question 2

Describe the Capital Asset Pricing Model (CAPM) and how it is used in capital budgeting decisions.
 
  What will be an ideal response?



asdfasdf

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

D

Answer to Question 2

CAPM is a procedure for adjusting a measure of the required rate of return on a firm's stock for risk. This risk-adjusted measure of the required rate of return on a firm's stock is used as the opportunity cost of capital in equity financing of a capital project. The projected cash flows from the project are discounted back to a net present value using this risk-adjusted rate of return. The risk adjustment is based on the Beta value of a firm's stock: the ratio of the volatility in the rate of return on a firm's stock to the volatility in the rate of return on a market portfolio of stocks.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library